Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention

Journal:
Journal of the National Cancer Institute
Published:
DOI:
10.1093/jnci/djaf137
Affiliations:
31
Authors:
28
Go to article
Institutions Authors Share
WHO International Agency for Research on Cancer (IARC), France
4.500000
 0.16
Imperial College London (ICL), United Kingdom (UK)
4.333333
 0.15
Leiden University Medical Center (LUMC), Netherlands
3.000000
 0.11
University of Bristol (UoB), United Kingdom (UK)
2.000000
 0.07
Institute for Human Development and Potential (IHDP), A*STAR, Singapore
1.500000
 0.05
University Hospital Carl Gustav Carus Dresden, TU Dresden, Germany
1.000000
 0.04
University of Hawaiʻi Cancer Center, United States of America (USA)
1.000000
 0.04
Wageningen University & Research (WUR), Netherlands
1.000000
 0.04
Johns Hopkins University (JHU), United States of America (USA)
1.000000
 0.04
Memorial University of Newfoundland (MUN), Canada
1.000000
 0.04
IRCCS National Cancer Institute (INT) Milan, Italy
1.000000
 0.04
Institute for the Study and Prevention of Cancer (ISPRO), Italy
1.000000
 0.04
University of Oxford, United Kingdom (UK)
1.000000
 0.04
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain
0.833333
 0.03
UK DRI at Imperial College London (UK DRI ICL), United Kingdom (UK)
0.833333
 0.03
Catalan Institute of Oncology (ICO), Spain
0.500000
 0.02
Bellvitge Biomedical Research Institute (IDIBELL), Spain
0.500000
 0.02
University of Barcelona (UB), Spain
0.500000
 0.02
University of Ioannina (UOI), Greece
0.500000
 0.02
Instituto de Salud Pública y Laboral de Navarra (ISPLN), Spain
0.333333
 0.01
Healthcare Research Institute of Navarre (IdiSNA), Spain
0.333333
 0.01
Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece
0.333333
 0.01
Interested in Cardiovascular Medicine and Haematology?